Digestive Remedies in the Czech Republic
Digestive remedies value sales grew by 2% in 2013, mostly as a result of growing average unit prices, which increased primarily due to the increased value-added tax rate. VAT for drugs in the Czech Republic increased from 14% in 2012 to 15% in January 2013. Manufacturers and retailers anticipated the increase and delayed unit price increases, using the rising VAT rate as a means to justify higher prices. As a result, all categories within digestive remedies recorded value sales growth in 2013.
Euromonitor International's Digestive Remedies in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to 2018 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.